Annual EBITDA
-$218.08 M
+$259.79 M+54.36%
December 31, 2024
Summary
- As of March 14, 2025, LEGN annual EBITDA is -$218.08 million, with the most recent change of +$259.79 million (+54.36%) on December 31, 2024.
- During the last 3 years, LEGN annual EBITDA has risen by +$174.30 million (+44.42%).
- LEGN annual EBITDA is now -146463.76% below its all-time high of $149.00 thousand, reached on December 31, 2018.
Performance
LEGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$52.46 M
+$162.37 M+147.73%
December 31, 2024
Summary
- As of March 14, 2025, LEGN quarterly EBITDA is $52.46 million, with the most recent change of +$162.37 million (+147.73%) on December 31, 2024.
- Over the past year, LEGN quarterly EBITDA has increased by +$188.10 million (+138.67%).
- LEGN quarterly EBITDA is now at all-time high.
Performance
LEGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$113.16 M
+$188.10 M+62.44%
December 31, 2024
Summary
- As of March 14, 2025, LEGN TTM EBITDA is -$113.16 million, with the most recent change of +$188.10 million (+62.44%) on December 31, 2024.
- Over the past year, LEGN TTM EBITDA has increased by +$364.71 million (+76.32%).
- LEGN TTM EBITDA is now -858.00% below its all-time high of -$11.81 million, reached on March 31, 2019.
Performance
LEGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LEGN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.4% | +138.7% | +76.3% |
| 3 y3 years | +44.4% | +138.7% | +76.3% |
| 5 y5 years | -74.6% | +138.7% | +76.3% |
LEGN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.4% | at high | +127.4% | at high | +77.2% |
| 5 y | 5-year | -74.6% | +54.4% | at high | +127.4% | at high | +77.2% |
| alltime | all time | <-9999.0% | +54.4% | at high | +127.4% | -858.0% | +77.2% |
Legend Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$218.08 M(-54.4%) | $52.46 M(-147.7%) | -$113.16 M(-62.4%) |
| Sep 2024 | - | -$109.91 M(+1444.3%) | -$301.26 M(+24.0%) |
| Jun 2024 | - | -$7.12 M(-85.4%) | -$243.00 M(-42.8%) |
| Mar 2024 | - | -$48.59 M(-64.2%) | -$424.79 M(-11.1%) |
| Dec 2023 | -$477.87 M(+14.7%) | -$135.64 M(+162.6%) | -$477.87 M(+2.1%) |
| Sep 2023 | - | -$51.65 M(-72.7%) | -$467.85 M(-5.0%) |
| Jun 2023 | - | -$188.91 M(+85.8%) | -$492.64 M(-0.5%) |
| Mar 2023 | - | -$101.68 M(-19.1%) | -$495.17 M(+16.6%) |
| Dec 2022 | -$416.54 M(+6.2%) | -$125.61 M(+64.3%) | -$424.57 M(+5.1%) |
| Sep 2022 | - | -$76.45 M(-60.1%) | -$403.96 M(-10.1%) |
| Jun 2022 | - | -$191.43 M(+515.9%) | -$449.20 M(+28.6%) |
| Mar 2022 | - | -$31.08 M(-70.4%) | -$349.31 M(-15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$392.38 M(+31.6%) | -$105.01 M(-13.7%) | -$412.79 M(+12.1%) |
| Sep 2021 | - | -$121.69 M(+32.9%) | -$368.39 M(+17.4%) |
| Jun 2021 | - | -$91.53 M(-3.2%) | -$313.67 M(-12.1%) |
| Mar 2021 | - | -$94.56 M(+56.0%) | -$356.93 M(+16.5%) |
| Dec 2020 | -$298.16 M(+138.7%) | -$60.61 M(-9.5%) | -$306.31 M(-0.3%) |
| Sep 2020 | - | -$66.96 M(-50.3%) | -$307.30 M(+14.6%) |
| Jun 2020 | - | -$134.79 M(+206.7%) | -$268.04 M(+65.8%) |
| Mar 2020 | - | -$43.95 M(-28.7%) | -$161.70 M(+24.8%) |
| Dec 2019 | -$124.89 M(<-9900.0%) | -$61.60 M(+122.3%) | -$129.57 M(+90.6%) |
| Sep 2019 | - | -$27.71 M(-2.6%) | -$67.97 M(+68.8%) |
| Jun 2019 | - | -$28.45 M(+140.8%) | -$40.26 M(+240.8%) |
| Mar 2019 | - | -$11.81 M | -$11.81 M |
| Dec 2018 | $149.00 K | - | - |
FAQ
- What is Legend Biotech annual EBITDA?
- What is the all time high annual EBITDA for Legend Biotech?
- What is Legend Biotech annual EBITDA year-on-year change?
- What is Legend Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for Legend Biotech?
- What is Legend Biotech quarterly EBITDA year-on-year change?
- What is Legend Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for Legend Biotech?
- What is Legend Biotech TTM EBITDA year-on-year change?
What is Legend Biotech annual EBITDA?
The current annual EBITDA of LEGN is -$218.08 M
What is the all time high annual EBITDA for Legend Biotech?
Legend Biotech all-time high annual EBITDA is $149.00 K
What is Legend Biotech annual EBITDA year-on-year change?
Over the past year, LEGN annual EBITDA has changed by +$259.79 M (+54.36%)
What is Legend Biotech quarterly EBITDA?
The current quarterly EBITDA of LEGN is $52.46 M
What is the all time high quarterly EBITDA for Legend Biotech?
Legend Biotech all-time high quarterly EBITDA is $52.46 M
What is Legend Biotech quarterly EBITDA year-on-year change?
Over the past year, LEGN quarterly EBITDA has changed by +$188.10 M (+138.67%)
What is Legend Biotech TTM EBITDA?
The current TTM EBITDA of LEGN is -$113.16 M
What is the all time high TTM EBITDA for Legend Biotech?
Legend Biotech all-time high TTM EBITDA is -$11.81 M
What is Legend Biotech TTM EBITDA year-on-year change?
Over the past year, LEGN TTM EBITDA has changed by +$364.71 M (+76.32%)